Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Milestone Scientific ( (MLSS) ) is now available.
On April 20, 2026, Milestone Scientific Inc. closed a $2.15 million private placement of 7,962,963 units, each comprising one share of common stock and a warrant priced at 125% of the $0.27 unit price, with potential for an additional $2.69 million in proceeds if all warrants are exercised for cash. The financing, conducted without a placement agent and in line with NYSE American rules, included approximately $1.80 million in cash and about $351,000 from the conversion of previously issued convertible bridge notes held by directors and officers.
Certain directors and officers, including the CEO and board members, participated on the same terms as other investors, adding $150,000 in cash purchases, while an independent board committee amended portions of the bridge notes to allow conversion at the private placement price within exchange constraints. Milestone plans to use the net proceeds to bolster working capital and pay past-due accounts payable, strengthening its balance sheet to support commercial growth initiatives in sales, inventory and digital marketing, with lock-up agreements and resale registration commitments shaping the transaction’s structure and investor protections.
The most recent analyst rating on (MLSS) stock is a Buy with a $1.00 price target. To see the full list of analyst forecasts on Milestone Scientific stock, see the MLSS Stock Forecast page.
Spark’s Take on MLSS Stock
According to Spark, TipRanks’ AI Analyst, MLSS is a Neutral.
The score is held down primarily by weak financial performance (persistent losses, ongoing cash burn, and reduced balance-sheet cushion). Technical indicators also reflect subdued momentum. Offsetting these, management’s 2026 growth and margin guidance and actions to improve financing flexibility provide some support, but execution and near-term liquidity remain key risks.
To see Spark’s full report on MLSS stock, click here.
More about Milestone Scientific
Milestone Scientific Inc. is a technology-focused medical research and development company that patents, designs and develops computerized injection technologies and instruments for medical and dental applications. Its proprietary computer-controlled systems, built on DPS Dynamic Pressure Sensing Technology, aim to make injections more precise, efficient and comfortable, with platform extensions into subcutaneous drug delivery, including local anesthetics.
The company targets both medical and dental markets that require accurate, safer drug delivery, positioning itself as a provider of next-generation devices that regulate flow rate and monitor pressure from the tip of the needle. By focusing on improving patient comfort and safety through advanced injection systems, Milestone seeks to differentiate itself within the broader medical device and dental technology industries.
Average Trading Volume: 1,882,625
Technical Sentiment Signal: Sell
Current Market Cap: $21.38M
Learn more about MLSS stock on TipRanks’ Stock Analysis page.